BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11969239)

  • 1. Adjuvant chemotherapy for colon cancer.
    Ducreux M; Boige V
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):283-98. PubMed ID: 11969239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
    Glimelius B; Dahl O; Cedermark B; Jakobsen A; Bentzen SM; Starkhammar H; Grönberg H; Hultborn R; Albertsson M; Påhlman L; Tveit KM;
    Acta Oncol; 2005; 44(8):904-12. PubMed ID: 16332600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant treatment of colonic carcinoma].
    Rochlitz CF; Herrmann R
    Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
    Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil.
    Grem JL
    Oncology (Williston Park); 1991 Mar; 5(3):63-70, 73; discussion 73-4. PubMed ID: 1829947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for colon and rectal cancer.
    Fuchs CS; Mayer RJ
    Semin Oncol; 1995 Oct; 22(5):472-87. PubMed ID: 7570058
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
    Schlag PM
    Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of chemotherapy in cancers of the colon].
    Seitz JF; Rougier P
    Bull Cancer; 1994 Apr; 81(4):260-76. PubMed ID: 7535602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What's new in adjuvant therapy of colorectal cancers?].
    Louvet C
    Ann Chir; 1998; 52(6):487-90. PubMed ID: 9752495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
    J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant therapy for colon cancer].
    Moiseenko VM; Orlova RV
    Vopr Onkol; 1998; 44(6):741-5. PubMed ID: 10087982
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant colon cancer chemotherapy: where we are and where we'll go.
    Lombardi L; Morelli F; Cinieri S; Santini D; Silvestris N; Fazio N; Orlando L; Tonini G; Colucci G; Maiello E
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S34-41. PubMed ID: 21129608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant systemic chemotherapy in colon cancer].
    Raskov HH
    Ugeskr Laeger; 1996 Feb; 158(9):1222-7. PubMed ID: 8644427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.